TerminatedPhase 3NCT00089141
Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Martin, Paul
- Principal Investigator
- Paul J. Martin, MDFred Hutchinson Cancer Center
- Intervention
- mycophenolate mofetil(drug)
- Enrollment
- 151 enrolled
- Eligibility
- 4 years · All sexes
- Timeline
- 2004 – 2008
Study locations (16)
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- Stanford Cancer Center, Stanford, California, United States
- University of Florida Shands Cancer Center, Gainesville, Florida, United States
- University of Chicago Cancer Research Center, Chicago, Illinois, United States
- University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
- Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
- UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska, United States
- Hackensack University Medical Center Cancer Center, Hackensack, New Jersey, United States
- Oregon Health and Science University Cancer Institute, Portland, Oregon, United States
- Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
- Baylor University Medical Center - Dallas, Dallas, Texas, United States
- M. D. Anderson Cancer Center at University of Texas, Houston, Texas, United States
- Texas Transplant Institute, San Antonio, Texas, United States
- Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
- University of Washington School of Medicine, Seattle, Washington, United States
- +1 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00089141 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.